News

Lilly to offer higher-dose versions of weight-loss drug on website
U.S. drugmaker Eli Lilly said on Monday it will offer the higher-dose versions of its popular weight-loss drug Zepbound on ...
Weight-Loss Medications Less Effective for People in the 'Real World,' New Study Finds
A new study found that weight-loss medications like Ozempic and Mounjaro are not as effective in a “real-world” setting ...
foxbangor.com5d
Real-World Results For GLP-1 Drugs Underwhelm, Study Says
WEDNESDAY, June 11, 2025 (HealthDay News) — Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and ...
Investing.com Nigeria5d
Hims & Hers stock falls after Lilly rules out partnership
Hims & Hers has been expanding its presence in the weight management market, with its existing Novo partnership representing ...
Weight-loss drugs were said to be a game changer. Turns out the benefit might be thinner than thought
Lastly, the researchers observed that while patients who discontinued obesity medications lost significantly less weight ...
News-Medical.Net5d
Real-world study finds lower weight loss with GLP-1 drugs due to early discontinuation
A Cleveland Clinic study shows that semaglutide and tirzepatide – injectable GLP-1 drugs for obesity – produce smaller weight ...
Injectable medications for obesity found to produce smaller weight loss in a real-world setting
A Cleveland Clinic study shows that semaglutide and tirzepatide—injectable GLP-1 drugs for obesity—produce smaller weight ...
Fox News21d
Study directly compares Zepbound and Wegovy for weight-loss results
Researchers compared the safety and efficacy of tirzepatide (brand name Zepbound) and semaglutide (brand name Wegovy) in a 72-week clinical trial. The randomized, controlled trial — called ...
Patients navigate an ‘absolutely insane’ maze to afford weight-loss drugs
Health insurance plans are changing how they cover GLP-1 drugs for weight loss to rein in costs, forcing doctors and patients ...